US FDA Approves GSK’s Blujepa for UTI Treatment in Women and Girls
26 Mar 2025
The US Food and Drug Administration (FDA) has approved Blujepa, a new antibiotic developed by GlaxoSmithKline (GSK), for the treatment of uncomplicated urinary tract infections (UTIs) in women and adolescent girls aged 12 and above. The approval marks a significant advancement in the fight against antibiotic-resistant bacteria, offering a new...
Read More
